Interestingly, in breast cancer, another study found that HER2 overexpression or continuous activation of ERK signaling can lead to epinephrine secretion in breast cancer cells, thereby upregulating the expression of the β2 receptor. This evidence concerns the gene ERBB2 and breast carcinoma.